Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Feb;18(2):157-69.

Immunoconglutinins in human saliva--a group of unusual IgA antibodies

Immunoconglutinins in human saliva--a group of unusual IgA antibodies

P J Lachmann et al. Immunology. 1970 Feb.

Abstract

It has been found that most normal human salivas contain high titres of immunoconglutinin activity (antibody to bound complement components). These salivary immunoconglutinins (IKs) have been found to show highly unusual properties.

Thus the activity is dependent on calcium ions and readily reversible by EDTA. On the basis of this property the salivary IKs have been substantially purified by absorption and elution from antigen—antibody—complement complexes. EDTA-reversibility is a characteristic property of bovine conglutinin but the salivary factors in all other ways behave as immunoconglutinins rather than conglutinin.

The activity is also uncharacteristically readily inhibited by the presence of free serum.

Antigenically the salivary IKs appear to be IgA but their sedimentation coefficient is greater than 19S even in molar acetic acid.

The origin and function of these salivary factors is unclear. IgA antibodies are generally believed not to fix complement, nor is whole complement activity present in saliva, so there is unlikely to be a good local antigenic stimulus. It may be that they represent antibodies to cross-reacting antigens.

PubMed Disclaimer

References

    1. Immunology. 1962 Nov;5:687-705 - PubMed
    1. J Immunol. 1966 Apr;96(4):637-45 - PubMed
    1. J Exp Med. 1965 Aug 1;122:277-98 - PubMed
    1. J Immunol. 1965 Jan;94:84-90 - PubMed
    1. Science. 1964 Mar 20;143(3612):1327-8 - PubMed

LinkOut - more resources